Skip to main content

Aggregator

Argus Research Upgrades Regeneron Pharmaceuticals to Buy from Hold

16 hours 48 minutes ago
Fintel reports that on October 1, 2026, Argus Research upgraded their outlook for Regeneron Pharmaceuticals (NASDAQGS:REGN) (BIT:1REGN) from Hold to Buy.Regeneron Pharmaceuticals, Inc. is an American biotechnology company primarily engaged in the research, development, and commer
Fintel

Stocks Climb on a Strong Forecast from Micron

16 hours 49 minutes ago
The S&P 500 Index ($SPX ) (SPY ) is up by +0.17% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.15%. December E-mini S&P futures (ESZ26 ) are up +0.13%, and December E-mini...
Barchart